EODData

FRA, RXK3: SELLAS Life Sciences Group Inc

07 Nov 2025
LAST:

1.388

CHANGE:
 0.05
OPEN:
1.388
HIGH:
1.388
ASK:
0.000
VOLUME:
1.0K
CHG(%):
3.21
PREV:
1.434
LOW:
1.388
BID:
0.000
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
07 Nov 251.3881.3881.3881.3881.0K
06 Nov 251.4341.4341.4341.4341.0K
05 Nov 251.3861.4741.3861.4741.0K
04 Nov 251.5521.5521.5141.5148.6K
31 Oct 251.6521.6521.6521.6525.0K
30 Oct 251.7501.7981.7501.7985.0K
29 Oct 251.7381.8161.7381.8167.6K
28 Oct 251.6181.6181.6181.6181.4K
27 Oct 251.7141.7141.6221.6221.4K
24 Oct 251.6261.6261.6261.6267.7K

COMPANY PROFILE

Name:SELLAS Life Sciences Group Inc
About:SELLAS Life Sciences Group, Inc., a late-stage clinical biopharmaceutical company, focuses on the development of novel therapeutics for various cancer indications in the United States. The company's lead product candidate is galinpepimut-S (GPS), a peptide immunotherapy directed against the Wilms tumor 1, antigen; and SLS009 (tambiciclib), a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor. It has a strategic collaboration with Merck & Co., Inc. to evaluate GPS as it is administered in combination with PD1 blocker pembrolizumab in a Phase 1/2 clinical trial enrolling patients in up to five cancer indications, including hematologic malignancies and solid tumors; and GenFleet Therapeutics (Shanghai), Inc. for the development and commercialization of GFH009. SELLAS Life Sciences Group, Inc. is headquartered in New York, New York.
Sector:Healthcare
Industry:Biotechnology
Address:7 Times Square, New York, NY, United States, 10036
Website:https://www.sellaslifesciences.com
ISIN:US81642T2096
LEI:549300VZIH50VYURLQ98

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:-3.03 
Forward P/E:-1.08 
PEG Ratio:0.07 
Price to Sales:27.98 
Price to Book:5.95 
Return on Assets:-0.69 
Return on Equity:-1.81 
Shares:105.3M 
Market Cap:146.15M 

TECHNICAL INDICATORS

MA5:1.497.5%
MA10:1.5914.9%
MA20:1.6720.3%
MA50:1.5813.5%
MA100:1.5411.1%
MA200:1.380.6%
RSI14:24.20 
WPR14:-100.00 
MTM14:-0.44
ROC14:-0.24 
ATR:0.14 
Week High:1.6519.0%
Week Low:1.390.1%
Month High:2.6087.3%
Month Low:1.390.6%
Year High:2.6087.3%
Year Low:0.8072.6%
Volatility:52.15 

RECENT SPLITS

Date Ratio
08 Nov 20191-50
02 Jan 20181-30
14 Nov 20161-20